ZZZheyu Zhang

Zheyu Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zheyu Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Longmin Fan

    5 shared publications
  • Weijun Peng

    Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China

    5 shared publications
  • Min Yi

    Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China

    4 shared publications
  • Haitao Jiang

    3 shared publications
  • Hongli Li

    Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China

    2 shared publications
  • Jianhua Huang

    Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410013, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Investigating causal effects of HDL-C on cognitive function through cross-sectional and Mendelian randomization analyses: concentration–response patterns and clues for Alzheimer’s disease prevention

    by Longmin Fan, Haitao Jiang, Zheyu Zhang

    Disrupted cholesterol homeostasis may accelerate cognitive aging. This study investigated the relationship between serum HDL-C levels and cognitive function, utilizing cross-sectional data and Mendelian randomization (MR) analysis. A cross-sectional study was conducted using data from the National Health and Nutrition Examination Survey (NHANES) 2011–2014, including 19,931 participants. Among them, 2,777 individuals aged 60 years and older with complete HDL-C levels and cognitive function data were included. Cognitive function was assessed using tests such as the Consortium to Establish a Registry for Alzheimer’s Disease Immediate and Delayed Recall, the Animal Fluency Test, and the Digit Symbol Substitution Test. Additionally, MR analysis was employed to assess the causal relationship between genetically predicted HDL-C and dementia. Gender-stratified analyses revealed sex-specific patterns in the relationship between HDL-C and cognitive function. In fully adjusted linear models, men showed consistently positive associations across all cognitive domains, including delayed recall (β = 0.10, 95% CI 0.04–0.17, p < 0.001), immediate recall (β = 0.06, 95% CI 0.00–0.12, p = 0.047), verbal fluency (β = 0.20, 95% CI 0.14–0.26, p < 0.001), processing speed (β = 0.09, 95% CI 0.05–0.14, p < 0.001), and overall composite score (β = 0.45, 95% CI 0.29–0.62, p < 0.001). In women, these associations were attenuated or non-significant for immediate recall, delayed recall, and composite cognition, suggesting non-linearity. Further concentration–response analyses revealed a linear positive association in men and an inverted U-shaped relationship in women. MR analyses indicated a protective association between genetically predicted HDL-C and Alzheimer’s disease risk (OR = 0.51, 95% CI 0.29–0.89, p = 0.019). However, sensitivity analyses revealed attenuation after MR-PRESSO outlier correction (β=-0.013, p = 0.756), and inconsistent estimates across methods, with significant heterogeneity (Q-test p < 0.001) and evidence of pleiotropy. In multivariable analysis, adjusting for LDL-C and TG, IVW (β = 0.290, p = 0.048) and Lasso regression (β = 0.752, p = 0.008) indicated weak positive correlations. However, MR-Egger (β = 0.752, p = 0.008) revealed potential pleiotropic interference (intercept p = 0.050). Our findings suggest that maintaining optimal serum HDL-C levels may help preserve cognitive function in older adults. Notably, sex-specific associations were observed, warranting further investigation into underlying mechanisms.


  • Serum Metabolites as Mediator Between Autoimmune Hyperthyroidism and Epilepsy: A Mendelian Randomization Analysis

    by Kai Zhang, Longmin Fan, Zheyu Zhang, Xinghui He

    Epilepsy, a complex neurological condition, might intertwine with various immune system anomalies, including autoimmune hyperthyroidism. An overactive thyroid gland due to immune system misdirection could subtly influence epilepsy via mechanisms not fully understood. Our investigation leverages Mendelian randomization (MR) to dissect this association, aiming to illuminate the role of serum metabolites as a possible bridge connecting these conditions. A comprehensive MR analysis was conducted in three phases, using genetic variants from GWAS datasets. The first phase assessed the causal effect of autoimmune hyperthyroidism on epilepsy. The second phase examined the impact of 1400 serum metabolites on epilepsy. The final phase explored the mediation of these metabolites in the autoimmune hyperthyroidism-epilepsy pathway. The analysis employed inverse variance weighted (IVW) methods, along with sensitivity analyses including MR-Egger and weighted median approaches, to ensure robustness. Our Mendelian randomization analysis identifies a significant causal relationship from autoimmune hyperthyroidism to epilepsy. We observed that genetic predisposition towards autoimmune hyperthyroidism is associated with reduced risk of developing epilepsy (P = 0.037). Sensitivity analyses, such as culling analysis and funnel plot inspections, confirm the consistency and robustness of this finding. Further analysis revealed cAMP as a mediator in this causal pathway (P = 0.016), underscoring its role in the link between autoimmune hyperthyroidism and epilepsy. Conversely, no causal effect of epilepsy on the development of autoimmune hyperthyroidism was found, highlighting a unidirectional relationship. This study proposes that autoimmune hyperthyroidism may act as a protective factor against epilepsy, with this effect potentially mediated by serum metabolites, particularly cAMP. These findings provide novel insights into the interplay between autoimmune conditions, metabolic alterations, and neurological disorders, highlighting cAMP as a promising therapeutic target of epilepsy. Graphical Abstract This graphical abstract illustrates the potential protective mechanism of autoimmune hyperthyroidism against epilepsy through the modulation of serum adenosine 3′,5′-cyclic monophosphate (cAMP) levels. Elevated thyroid hormone levels in autoimmune hyperthyroidism may enhance adenylate cyclase activity, increasing the conversion of ATP to cAMP, while simultaneously affecting phosphodiesterase function, reducing cAMP breakdown and leading to its accumulation. The increased cAMP levels may upregulate the GABAergic pathway, thereby dampening neuronal excitability and lowering the likelihood of seizures. Our study, leveraging a Mendelian randomization approach, provides evidence that autoimmune hyperthyroidism is associated with a decreased risk of epilepsy, a finding supported by extensive sensitivity analyses, including MR-Egger regression. Further investigation into the specific mechanisms, including the role of CREB and its impact on ion channels and neurotransmitter systems, is necessary to fully understand the complex interplay between autoimmune disorders and neurological diseases, and to establish novel therapeutic strategies for epilepsy management. Illustrations created at BioRender.com


  • Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy

    by Xin Cheng, Yejun Tan, Hongli Li, Zhen Zhang, Shan Hui, Zheyu Zhang, Weijun Peng

    Diabetic encephalopathy (DE) is a complication of diabetes, especially type 2 diabetes (T2D), characterized by damage in the central nervous system and cognitive impairment, which has gained global attention. Despite the extensive research aimed at enhancing our understanding of DE, the underlying mechanism of occurrence and development of DE has not been established. Mounting evidence has demonstrated a close correlation between DE and various factors, such as Alzheimer’s disease-like pathological changes, insulin resistance, inflammation, and oxidative stress. Of interest, nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor with antioxidant properties that is crucial in maintaining redox homeostasis and regulating inflammatory responses. The activation and regulatory mechanisms of NRF2 are a relatively complex process. NRF2 is involved in the regulation of multiple metabolic pathways and confers neuroprotective functions. Multiple studies have provided evidence demonstrating the significant involvement of NRF2 as a critical transcription factor in the progression of DE. Additionally, various molecules capable of activating NRF2 expression have shown potential in ameliorating DE. Therefore, it is intriguing to consider NRF2 as a potential target for the treatment of DE. In this review, we aim to shed light on the role and the possible underlying mechanism of NRF2 in DE. Furthermore, we provide an overview of the current research landscape and address the challenges associated with using NRF2 activators as potential treatment options for DE.


  • Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer’s disease: a systematic review and meta-analysis

    by Longmin Fan, Zheyu Zhang

    Curcumin, a polyphenol derived from the herb turmeric, has emerged as a prospective potential therapy in the treatment of Alzheimer’s disease (AD). However, the efficacy of curcumin treatment in improving cognitive decline caused controversy recently. We aimed to systematically review the effect of curcumin on cognitive impairment in an animal model of AD. We conducted an exhaustive database search of related studies. Two investigators identified studies and independently extracted data. Stratified meta-analyses and meta-regression analyses were carried out to explore the sources of heterogeneity. Publication bias was assessed using funnel plots and Egger’s test. Our systematic review included 33 articles. A meta-analysis of 29 publications showed that curcumin exerts significant positive effects on cognitive performance. For acquisition, the global estimated effect of curcumin was − 2.027 (95% CI − 2.435 to − 1.619, p < 0.001); for retention, the global estimated effect of curcumin was 1.606 (95% CI 1.101 to 2.111, p < 0.001). The stratified meta-analysis demonstrated that an increased effect size depended on diverse study characteristics. Additionally, publication bias was detected. We conclude that curcumin may reduce cognitive deficits in experimental AD. Furthermore, we emphasize that additional well-designed and well-reported animal studies are needed to inform further clinical studies.


  • Neuroimmune mechanisms underlying Alzheimer’s disease: Insights into central and peripheral immune cell crosstalk

    by Yuqing Liu, Yejun Tan, Zheyu Zhang, Hongli Li, Min Yi, Zhen Zhang, Shan Hui, Weijun Peng


  • Open Access

    Protective Effect of Quercetin against H2O2-Induced Oxidative Damage in PC-12 Cells: Comprehensive Analysis of a lncRNA-Associated ceRNA Network

    by Zheyu Zhang, Pengji Yi, Min Yi, Xiaoliang Tong, Xin Cheng, Jingjing Yang, Yang Hu, Weijun Peng

    Quercetin is a bioflavonoid with potential antioxidant properties. However, the mechanisms underlying its effects remain unclear. Herein, we focused on integrating long noncoding RNA (lncRNA), microRNA (miRNA), and messenger RNA (mRNA) sequencing of PC-12 cells treated with quercetin. We treated PC-12 cells with hydrogen peroxide to generate a validated oxidative damage model. We evaluated the effects of quercetin on PC-12 cells and established the lncRNA, miRNA, and mRNA profiles of these cells. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses of these RNAs were conducted to identify the key pathways. Quercetin significantly protected PC-12 neuronal cells from hydrogen peroxide-induced death. We identified 297, 194, and 14 significantly dysregulated lncRNAs, miRNAs, and mRNAs, respectively, associated with the antioxidant effect of quercetin. Furthermore, the phosphatidylinositol-3-kinase/protein kinase B pathway was identified as the crucial signalling pathway. Finally, we constructed a lncRNA-associated competing endogenous RNA (ceRNA) network by utilizing oxidative damage mechanism-matched miRNA, lncRNA, and mRNA expression profiles and those changed by quercetin. In conclusion, quercetin exerted a protective effect against oxidative stress-induced damage in PC-12 cells. Our study provides novel insight into ceRNA-mediated gene regulation in the progression of oxidative damage and the action mechanisms of quercetin.


  • Open Access

    Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer

    by Siqi Huang, Zheyu Zhang, Wenqun Li, Fanhua Kong, Pengji Yi, Jianhua Huang, Dan Mao, Weijun Peng, Sifang Zhang

    Background: Zuojinwan (ZJW), a famous Chinese medicine formula, has been widely used to treat colorectal cancer (CRC). However, its bioactive compounds, potential targets, and molecular mechanism remain largely elusive. Aim: A network pharmacology-based strategy combined with molecular docking studies and in vitro validation were employed to investigate bioactive compounds, potential targets, and molecular mechanism of ZJW against CRC. Materials and Methods: Bioactive compounds and potential targets of ZJW, as well as related genes of CRC, were acquired from public databases. Important ingredients, potential targets, and signaling pathways were determined through bioinformatics analysis, including protein–protein interaction (PPI), the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking and cell experiments were performed to further verify the findings. Results: A total of 36 bioactive ingredients of ZJW and 163 gene targets of ZJW were identified. The network analysis revealed that quercetin, baicalein, wogonin, beta-sitosterol, and isorhamnetin may be candidate agents. The AKT1, JUN, CDKN1A, BCL2L1, and NCOA1 could become potential drug targets. The KEGG indicated that PI3K-AKT signaling pathway may play an important role in the effect of ZJW against CRC. Molecular docking suggested that quercetin, baicalein, and wogonin combined well with AKT1 and JUN. The in vitro experiment showed that quercetin, the most important ingredient of ZJW, could induce apoptosis of HCT116 cells through PI3K-Akt signaling pathway. This finding was congruent with the prediction obtained through the network pharmacology approach. Conclusion: This study comprehensively illuminated the active ingredients, potential targets, and molecular mechanism of ZJW against CRC. It also provided a promising approach to uncover the scientific basis and therapeutic mechanism of traditional Chinese medicine (TCM) formula treating for disease.


  • Open Access

    Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer’s Disease

    by Min Yi, Chunhu Zhang, Zheyu Zhang, Pengji Yi, Panpan Xu, Jianhua Huang, Weijun Peng

    Bushen Tiansui Formula (BSTSF) is a traditional Chinese medicine prescription. It has been widely applied to treat Alzheimer’s disease (AD) in the clinic; however, the mechanisms underlying its effects remain largely unknown. In this study, we used a rat AD model to study the effects of BSTSF on cognitive performance, and UPLC-MS/MS-based metabolomic and lipidomic analysis was further performed to identify significantly altered metabolites in the cerebral cortices of AD rats and determine the effects of BSTSF on the metabolomic and lipidomic profiles in the cerebral cortices of these animals. The results revealed that the levels of 47 metabolites and 30 lipids primarily associated with sphingolipid metabolism, glycerophospholipid metabolism, and linoleic acid metabolism were significantly changed in the cerebral cortices of AD rats. Among the altered lipids, ceramides, phosphatidylethanolamines, lysophosphatidylethanolamines, phosphatidylcholines, lysophosphatidylcholines, phosphatidylserines, sphingomyelins, and phosphatidylglycerols showed robust changes. Moreover, 34 differential endogenous metabolites and 21 lipids, of which the levels were mostly improved in the BSTSF treatment group, were identified as potential therapeutic targets of BSTSF against AD. Our results suggest that lipid metabolism is highly dysregulated in the cerebral cortices of AD rats, and BSTSF may exert its neuroprotective mechanisms by restoring metabolic balance, including that of sphingolipid metabolism, glycerophospholipid metabolism, alanine, aspartate, and glutamate metabolism, and D-glutamine and D-glutamate metabolism. Our data may lead to a deeper understanding of the AD-associated metabolic profile and shed new light on the mechanism underlying the therapeutic effects of BSTSF.